Skip to main content
. 2019 Oct;11(10):4282–4291. doi: 10.21037/jtd.2019.09.60

Table 3. The characteristics, treatment and prognosis of dead patients with lung cancer.

No. Sex Age Smoking Tumor location Histological type Clinical stage Surgical approach Surgical treatment Adjuvant therapy Cause of death OS (month)
1 Female 17 No RUL EMC IB OTS Lobectomy No Breast cancer 33
2 Male 28 Yes RML AC IIIA OTS Lobectomy Chemoradiotherapy Recurrence of lung cancer 32
3 Male 30 No RUL AC IIIA OTS Lobectomy Chemoradiotherapy Other tumor 36
4 Female 27 No RLL MTs (cervical cancer) VATS Wedge resection Chemotherapy Multiple metastasis of cervical cancer 11
5 Male 20 No LUL + LLL CS IIB OTS Pneumonectomy No Recurrence of lung cancer 9
6 Male 27 No RLL + LUL MTs (chondrosarcoma) VATS Segmentectomy + wedge resection No Multiple metastasis of chondrosarcoma 6
7 Female 21 No RLL MTs (osteosarcoma) VATS Lobectomy Chemotherapy Multiple metastasis of osteosarcoma 5

RUL, right upper lobe; RML, right middle lobe; RLL, right lower lobe; LUL, left upper lobe; LLL, left lower lobe; AC, adenocarcinoma; EMC, epithelial-myoepithelial carcinoma; CS, carcinosarcoma; MTs, metastatic tumors; OTS, open thoracic surgery; VATS, video-assisted thoracic surgery; OS, overall survival.